NCT03312972View on ClinicalTrials.gov

Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 28, 2017

Primary Completion Date

March 31, 2026

Study Completion Date

July 31, 2026

Conditions

Locally Recurrent Prostate Cancer

Interventions

RADIATION

HDR Brachytherapy

HDR Brachytherapy implant, deliver 1 to 2 fractions, Up to 30 Gray (Gy) to target lesion

Trial Locations (2)

22908

University of Virginia School of Medicine, Charlottesville

60153

Loyola University Medical Center, Maywood

All Listed Sponsors

lead

Loyola University

OTHER

NCT03312972 - Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy | Biotech Hunter | Biotech Hunter